| |
|
|
| Name: |
Casdin Capital LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10019 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
46 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
WGS |
GeneDx Holdings Corp |
1 |
- |
$91.61 |
$310,612,000 |
3,507,164 |
25.38% |
41,051,000 |
0 |
13.705 |
N/A |
|
|
BLFS |
Biolife Solutions Inc |
2 |
- |
$22.84 |
$198,872,000 |
8,707,165 |
16.25% |
-27,166,000 |
0 |
18.407 |
Biotechnology |
|
|
RVMD |
Revolution Medicines, Inc. |
3 |
- |
$37.87 |
$130,759,000 |
3,697,933 |
10.68% |
-31,048,000 |
-1,350 |
2.175 |
N/A |
|
|
FLDM |
Fluidigm Corp |
4 |
- |
$1.35 |
$82,162,000 |
76,075,636 |
6.71% |
-42,534,000 |
4,820,959 |
20.497 |
Scientific & Technica... |
|
|
RNA |
Avidity Biosciences, Inc. |
5 |
- |
$29.17 |
$60,368,000 |
2,045,000 |
4.93% |
899,000 |
0 |
1.515 |
N/A |
|
|
SRPT |
Sarepta Therapeutics Inc |
6 |
- |
$18.24 |
$57,488,000 |
900,783 |
4.7% |
-73,039,000 |
-172,717 |
0.945 |
Drug Manufacturers - ... |
|
|
ILMN |
Illumina Inc |
7 |
- |
$100.80 |
$47,207,000 |
595,000 |
3.86% |
-53,016,000 |
-155,000 |
0.408 |
Scientific & Technica... |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
8 |
- |
$331.91 |
$32,402,000 |
120,000 |
2.65% |
-541,000 |
-20,000 |
0.098 |
Biotechnology |
|
|
BPMC |
Blueprint Medicines Corp |
9 |
- |
$128.35 |
$28,888,000 |
326,378 |
2.36% |
421,000 |
0 |
0.494 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
10 |
- |
$20.01 |
$27,841,000 |
1,425,562 |
2.27% |
-3,159,000 |
175,562 |
1.749 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
11 |
- |
$3.63 |
$23,838,000 |
9,098,574 |
1.95% |
-13,030,000 |
150,000 |
5.448 |
N/A |
|
|
CDXS |
Codexis Inc |
12 |
- |
$2.77 |
$21,789,000 |
8,100,000 |
1.78% |
-16,848,000 |
0 |
12.484 |
Biotechnology |
|
|
VERV |
Verve Therapeutics, Inc. |
13 |
- |
$0.00 |
$18,260,000 |
3,995,571 |
1.49% |
-4,275,000 |
0 |
4.968 |
N/A |
|
|
EXAS |
Exact Sciences Corp |
14 |
- |
$53.36 |
$17,532,000 |
405,000 |
1.43% |
-18,992,000 |
-245,000 |
0.219 |
Biotechnology |
|
|
NGNE |
Neurogene |
15 |
- |
$3.68 |
$15,169,000 |
1,295,361 |
1.24% |
-14,443,000 |
0 |
3.092 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
16 |
- |
$10.74 |
$14,220,000 |
2,000,000 |
1.16% |
-9,100,000 |
0 |
1.969 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
17 |
- |
$14.69 |
$13,459,000 |
990,000 |
1.1% |
-6,717,000 |
0 |
0.692 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
18 |
- |
$20.37 |
$12,117,000 |
700,000 |
0.99% |
-6,867,000 |
0 |
1.111 |
N/A |
|
|
BGNE |
Beigene Ltd |
19 |
New |
$245.49 |
$10,887,000 |
40,000 |
0.89% |
10,887,000 |
40,000 |
0.044 |
N/A |
|
|
GH |
Guardant Health, Inc. |
20 |
- |
$0.00 |
$10,650,000 |
250,000 |
0.87% |
-43,000 |
-100,000 |
0.192 |
N/A |
|
|
MAZE |
Maze Therapeutics, Inc. |
21 |
New |
$11.50 |
$10,419,000 |
946,357 |
0.85% |
10,419,000 |
946,357 |
2.161 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
22 |
- |
$0.00 |
$9,880,000 |
2,000,000 |
0.81% |
4,000,000 |
0 |
3.849 |
N/A |
|
|
VCYT |
Veracyte, Inc. |
23 |
- |
$27.51 |
$8,193,000 |
276,308 |
0.67% |
-2,749,000 |
0 |
0.334 |
Biotechnology |
|
|
GEHC |
Ge Healthcare Holding Llc |
24 |
New |
$76.07 |
$8,071,000 |
100,000 |
0.66% |
8,071,000 |
100,000 |
0.022 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
25 |
- |
$9.00 |
$7,801,000 |
635,000 |
0.64% |
1,521,000 |
160,000 |
0.675 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
26 |
- |
$36.07 |
$7,325,000 |
250,000 |
0.6% |
-890,000 |
0 |
0.362 |
N/A |
|
|
MRNA |
Moderna, Inc. |
27 |
- |
$0.00 |
$6,379,000 |
225,000 |
0.52% |
-898,000 |
50,000 |
0.057 |
N/A |
|
|
HIMS |
Hims & Hers Health, Inc. |
28 |
New |
$47.98 |
$5,910,000 |
200,000 |
0.48% |
5,910,000 |
200,000 |
0.109 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
29 |
- |
$0.00 |
$3,838,000 |
6,732,971 |
0.31% |
-5,790,000 |
0 |
10.522 |
N/A |
|
|
VSTM |
Verastem, Inc. |
30 |
New |
$4.80 |
$3,618,000 |
600,000 |
0.3% |
3,618,000 |
600,000 |
1.333 |
Biotechnology |
|
|
SEPN |
Septerna, Inc. |
31 |
- |
$11.37 |
$3,203,000 |
553,268 |
0.26% |
-9,467,000 |
0 |
1.246 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
32 |
New |
$5.03 |
$2,868,000 |
775,000 |
0.23% |
2,868,000 |
775,000 |
2.008 |
N/A |
|
|
ABSI |
Absci Corp |
33 |
- |
$2.77 |
$2,443,000 |
973,260 |
0.2% |
-107,000 |
0 |
1.058 |
N/A |
|
|
TDOC |
Teladoc, Inc. |
34 |
New |
$8.29 |
$2,388,000 |
300,000 |
0.2% |
2,388,000 |
300,000 |
0.207 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
35 |
- |
$0.00 |
$1,529,000 |
3,212,316 |
0.12% |
-3,713,000 |
-1,978,190 |
5.86 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
36 |
New |
$8.76 |
$1,046,000 |
100,000 |
0.09% |
1,046,000 |
100,000 |
0.087 |
N/A |
|
|
CTNM |
Contineum Therapeutics, Inc. |
37 |
- |
$3.88 |
$1,035,000 |
148,333 |
0.08% |
-3,311,000 |
-148,333 |
0.577 |
N/A |
|
|
RXRX |
Recursion Pharmaceuticals, ... |
38 |
- |
$5.27 |
$875,000 |
165,323 |
0.07% |
-243,000 |
0 |
0.061 |
N/A |
|
|
PACB |
Pacific Biosciences Of Cali... |
39 |
- |
$1.60 |
$854,000 |
723,767 |
0.07% |
-1,042,000 |
-312,092 |
0.241 |
Biotechnology |
|
|
PRME |
Prime Medicine, Inc. |
40 |
- |
$3.11 |
$731,000 |
367,175 |
0.06% |
-341,000 |
0 |
0.378 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
41 |
- |
$0.00 |
$399,000 |
86,014 |
0.03% |
-198,000 |
0 |
0.14 |
N/A |
|
|
DNA |
Ginkgo Bioworks Holdings, Inc |
42 |
- |
$12.72 |
$208,000 |
36,493 |
0.02% |
-150,000 |
0 |
0.002 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
43 |
- |
$0.00 |
$171,000 |
125,000 |
0.01% |
-3,501,000 |
-1,063,349 |
0.123 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
44 |
- |
$0.00 |
$102,000 |
123,839 |
0.01% |
-16,000 |
0 |
0.221 |
N/A |
|
|
FTRE |
Fortrea Holdings Inc. |
46 |
Closed |
$5.22 |
$0 |
0 |
0% |
-5,129,000 |
-275,000 |
0 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
45 |
Closed |
$0.00 |
$0 |
0 |
0% |
-6,406,000 |
-1,150,000 |
0 |
N/A |
|
